Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Product Innovation Times.
Press releases published on April 21, 2025

Potential Business Insights from Zudio's Thriving Streak in Dubai
YRC shares insights from Zudio’s Dubai success to help fashion entrepreneurs refine business ideas and retail strategies for 2025. PUNE, MAHARASHTRA, INDIA, April 21, 2025 /EINPresswire.com/ -- In this communiqué, the team of 𝗳𝗮𝘀𝗵𝗶𝗼𝗻 𝗿𝗲𝘁𝗮𝗶𝗹 𝗰𝗼𝗻𝘀𝘂𝗹𝘁𝗮𝗻𝘁𝘀 …

Fractal Forest Methylene Blue: Pharmaceutical-Grade Ingredients to Support Mitochondrial health
New York City, April 21, 2025 (GLOBE NEWSWIRE) -- Introduction Why So Many Are Struggling With Chronic Fatigue, Brain Fog, and Low Energy In today's fast-paced world, an increasing number of individuals are grappling with persistent fatigue, mental fog, …

Pixalate’s March 2025 Top Grossing Mobile and CTV Apps in North America: ‘My FitnessPal’ Ranked No. 1 on Apple App Store in Canada; ‘Hulu’ No. 1 Across Roku, Amazon Fire TV, Samsung Smart TV, & Apple TV in U.S.
London, April 21, 2025 (GLOBE NEWSWIRE) -- Pixalate, a leading global platform for ad fraud protection, privacy, and compliance analytics, today released the March 2025 North America Top Grossing Apps Reports for the United States and Canada. The reports …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Kyndryl Holdings, Inc. – KD
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE: KD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …

Zenas BioPharma, Inc. Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against ZBIO
SAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons who purchased or otherwise acquired Zenas BioPharma, Inc. (NASDAQ: ZBIO) securities pursuant and/or traceable to the …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Movado Group, Inc. – MOV
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Movado Group, Inc. (“Movado” or the “Company”) (NYSE: MOV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646- …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CarMax, Inc. – KMX
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of CarMax, Inc. (“CarMax” or the “Company”) (NYSE: KMX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980 …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI). Such investors are advised to contact Danielle Peyton at …

Semtech Corporation Investors: Please contact the Portnoy Law Firm to recover your losses. April 22, 2025 Deadline to file Lead Plaintiff Motion
LOS ANGELES, April 21, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Semtech Corporation ("Semtech Corporation" or the "Company") (NASDAQ: SMTC) investors of a class action representing investors that bought securities between August 27, 2024 and …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agilysys, Inc. - AGYS
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Agilysys, Inc. (“Agilysys” or the “Company”) (NASDAQ: AGYS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646 …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Pliant Therapeutics, Inc (“Pliant” or the “Company”) (NASDAQ: PLRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Horizon Technology Finance Corporation - HRZN
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Horizon Technology Finance Corporation (“Horizon” or the “Company”) (NASDAQ: HRZN). Such investors are advised to contact Danielle Peyton at …

XRP News: XenDex Announces Vision, Native Token Utility Framework, and Detailed Tokenomics
SYDNEY, April 21, 2025 (GLOBE NEWSWIRE) -- XenDex, a groundbreaking all-in-one decentralized exchange, is officially entering the Ripple blockchain with a bold mission: to create the first all-in-one decentralized finance hub built natively on the XRP …

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Penumbra, Inc. (NYSE: PEN) and Encourages Current Penumbra Shareholders to Contact the Firm
PHILADELPHIA, April 21, 2025 (GLOBE NEWSWIRE) -- The law firm of Kaskela Law LLC is investigating Penumbra, Inc. (NYSE: PEN) on behalf of the company’s current shareholders. Click here for additional information: https://kaskelalaw.com/case/penumbra/ The …

Fluence Energy, Inc. Stock News: Robbins LLP Reminds Stockholders of the Securities Fraud Class Action Lawsuit Filed Against FLNC
SAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP reminds investors it has filed a class action lawsuit on behalf of all purchasers of Fluence Energy, Inc. ("Fluence") (NASDAQ: FLNC) Class A stock between October 28, …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Biohaven Ltd. (“Biohaven” or the “Company”) (NYSE: BHVN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646- …

Fungabeam Toenail Fungus Device Under Review: Best Low-Level Laser Therapy to Get Rid of Stubborn Nail Fungus For Good
New York City, April 21, 2025 (GLOBE NEWSWIRE) -- Introduction: Why Nail Fungus Is More Than Just a Cosmetic Problem Nail fungus isn’t just an embarrassing condition. For millions of people, it’s a recurring battle — thick, discolored, brittle nails that …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Teleflex Incorporated (“Teleflex” or the “Company”) (NYSE: TFX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. (“PepGen” or the “Company”) (NASDAQ: PEPG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581- …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Valneva SE (“Valneva” or the “Company”) (NASDAQ: VALN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581- …